CNC
CENTENE CORP
NYSE · Healthcare · Medical - Healthcare Plans · US
$70.17
−1.50%Year over year
Reported trailing growth
- Revenue
- +8.7%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- +730.4%
- Operating cash flow
- +464.5%
Forward estimates
Based on analyst estimates
- Revenue
- -0.8%
- EBITDA
- +291.7%
- EPS
- +148.8%
Three-year CAGR
- Revenue
- +10.5%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- -6.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026